Adverse Event Reporting in Cancer Clinical Trial Publications
Adverse Event Reporting in Cancer Clinical Trial Publications
Reporting adverse events is a critical element of a clinical trial publication. In 2003, the Consolidated Standards of Reporting Trials (CONSORT) group generated recommendations regarding the appropriate reporting of adverse events. The degree to which these recommendations are followed in oncology publications has not been comprehensively evaluated.A review of citations …